Abstract
SummaryViruses have evolved many different ways to evade immune attacks. The adenoviral E3 protein 14·7K effectively inhibits antiviral immunity and inflammation. However, the underlying mechanism for this effect is unclear. Here we show that 14·7K is a potent inhibitor of nuclear factor (NF)‐κB transcriptional activity following Toll‐like receptor (TLR) or tumour necrosis factor (TNF) receptor signalling. The inhibition of the NF‐κB activity occurs downstream of IκBα degradation and NF‐κB translocation into the nucleus. Analysis of NF‐κB DNA binding reveals that 14·7K specifically inhibits p50 homodimer DNA binding and that this inhibition is mediated through the interaction of 14·7K with p50. We propose that 14·7K inhibits NF‐κB activity through directly blocking p50 binding to DNA and that this is the basis for its anti‐inflammatory properties. Our data also indicate a role for p50 homodimer‐dependent transcription in inflammation.
References
35
Referenced
15
10.1128/jvi.70.4.2431-2439.1996
/ J Virol / The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model by Sparer TE (1996)10.1073/pnas.86.10.3823
10.1152/ajplung.2000.278.4.L631
10.1089/10430340252939032
10.1128/JVI.65.5.2629-2639.1991
10.1128/JVI.75.19.8875-8887.2001
10.1074/jbc.275.13.9882
10.1172/JCI11918
10.1016/S0002-9440(10)64804-3
10.4049/jimmunol.155.2.910
/ J Immunol / Induction of oral tolerance to myelin basic protein in CD8‐depleted mice. both CD4+ and CD8+ cells mediate active suppression by Chen Y (1995)10.1128/JVI.76.11.5515-5521.2002
10.2337/diabetes.52.5.1119
10.1073/pnas.92.15.6947
10.1074/jbc.273.10.5815
10.1006/viro.2000.0738
10.1128/JVI.71.11.8299-8306.1997
10.1038/33712
10.1073/pnas.95.17.10072
10.1016/S0006-2952(00)00393-2
10.1038/nm0197-20
10.1146/annurev.genet.33.1.29
10.1146/annurev.immunol.16.1.225
10.1084/jem.187.7.985
10.1101/gad.6.5.775
10.1074/jbc.M108294200
10.1074/jbc.270.39.23077
10.1073/pnas.93.22.12376
10.1046/j.1432-1033.2000.01778.x
10.1101/gad.7.7b.1354
10.1128/MCB.23.8.2749-2761.2003
10.1074/jbc.M303076200
10.1074/jbc.M211831200
10.1074/jbc.M209814200
10.1038/nature02738
10.1128/JVI.77.2.1112-1119.2003
Dates
Type | When |
---|---|
Created | 19 years, 9 months ago (Nov. 29, 2005, 5:45 a.m.) |
Deposited | 1 year, 10 months ago (Oct. 13, 2023, 1:49 p.m.) |
Indexed | 1 year, 2 months ago (June 19, 2024, 7:56 a.m.) |
Issued | 19 years, 9 months ago (Nov. 29, 2005) |
Published | 19 years, 9 months ago (Nov. 29, 2005) |
Published Online | 19 years, 9 months ago (Nov. 29, 2005) |
Published Print | 19 years, 7 months ago (Feb. 1, 2006) |
@article{Carmody_2005, title={A novel mechanism of nuclear factor‐κB regulation by adenoviral protein 14·7K}, volume={117}, ISSN={1365-2567}, url={http://dx.doi.org/10.1111/j.1365-2567.2005.02277.x}, DOI={10.1111/j.1365-2567.2005.02277.x}, number={2}, journal={Immunology}, publisher={Wiley}, author={Carmody, Ruaidhrí J. and Maguschak, Kimberly and Chen, Youhai H.}, year={2005}, month=nov, pages={188–195} }